Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lazarus

Showing results (381-390 of 434) with videos related to

Pageof 44
Sort By:
Plos Neglected Tropical Diseases|January 20, 2017
Integrated Control and Management of Neglected Tropical Skin DiseasesOriol Mitjà, Michael Marks, Laia Bertran, et al.
Communications Medicine|October 30, 2024
Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteriaLuis Antonio Díaz, Jeffrey V Lazarus, Eduardo Fuentes-López, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 7, 2019
Securing sustainable funding for viral hepatitis elimination plansAngelos Hatzakis, Jeffrey V Lazarus, Evangelos Cholongitas, et al.
Metabolism: Clinical and Experimental|June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
International Health|May 11, 2021
Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemicJong-Koo Lee, Chris Bullen, Yanis Ben Amor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2025
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six CountriesJeffrey V Lazarus, Leire Agirre-Garrido, J Emilio Miralles-Sanchez, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
The International Journal on Drug Policy|July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugsJason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
Eclinicalmedicine|January 9, 2023
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019Daniela K van Santen, Rachel Sacks-Davis, Ashleigh Stewart, et al.
Pageof 44

Showing results (381-390 of 434) with videos related to

Sort By:
Pageof 44
Plos Neglected Tropical Diseases|January 20, 2017
Integrated Control and Management of Neglected Tropical Skin DiseasesOriol Mitjà, Michael Marks, Laia Bertran, et al.
Communications Medicine|October 30, 2024
Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteriaLuis Antonio Díaz, Jeffrey V Lazarus, Eduardo Fuentes-López, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 7, 2019
Securing sustainable funding for viral hepatitis elimination plansAngelos Hatzakis, Jeffrey V Lazarus, Evangelos Cholongitas, et al.
Metabolism: Clinical and Experimental|June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
International Health|May 11, 2021
Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemicJong-Koo Lee, Chris Bullen, Yanis Ben Amor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2025
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six CountriesJeffrey V Lazarus, Leire Agirre-Garrido, J Emilio Miralles-Sanchez, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
The International Journal on Drug Policy|July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugsJason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
Eclinicalmedicine|January 9, 2023
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019Daniela K van Santen, Rachel Sacks-Davis, Ashleigh Stewart, et al.
Pageof 44